The most important comparison to me was based on price.
I'm very confident you would feel differently if you suffered from LN.
How effective the drug is (efficacy) is the most important factor.
Lupkynis blows Benlysta out of the water in terms of its ability to save people from diabetes, dialysis, kidney transplant, etc.
You admit you didn't read the report.
I suggest you should and would be amazed if you are not struck by its glaring flaws.
That Benlysta is rated as effective as Lupkynis is a gross misrepresentation bordering on fraud.
The final report will tell the story, but right now it looks like GSK has either bamboozled ICER or worse.
News 
Market Data 
Discover 
